Mostrar el registro sencillo del ítem
Current insights into antibiotic resistance in uropathogenic Escherichia coli and interventions using selected bioactive phytochemicals
| dc.contributor.author | Futoma-Kołoch, Bożena | |
| dc.contributor.author | Sarowska, Jolanta | |
| dc.contributor.author | Abdelsalam, Mohamed | |
| dc.contributor.author | Miñana-Galbis, David | |
| dc.contributor.author | Drabová, Barbora | |
| dc.contributor.author | Guz-Regner, Katarzyna | |
| dc.contributor.author | Wiśniewska, Paula | |
| dc.contributor.author | Kryniewska, Vivien | |
| dc.date.accessioned | 2026-06-04T11:50:43Z | |
| dc.date.available | 2026-06-04T11:50:43Z | |
| dc.date.issued | 2025-12 | |
| dc.identifier.citation | Futoma-Kołoch B, Sarowska J, Abdelsalam M, Miñana-Galbis D, Drabová B, Guz-Regner K, Wiśniewska P, Kryniewska V. Current insights into antibiotic resistance in uropathogenic Escherichia coli and interventions using selected bioactive phytochemicals. Antibiotics. 2025 Dec;14(12):1242. DOI: 10.3390/antibiotics14121242 | ca |
| dc.identifier.issn | 2079-6382 | ca |
| dc.identifier.uri | https://hdl.handle.net/20.500.12367/3237 | |
| dc.description.abstract | Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infections (UTIs) and a major contributor to the global antimicrobial resistance crisis. The increasing prevalence of multidrug-resistant (MDR) strains, including expanded-spectrum β-lactamases (ESBL) and carbapenemase-producing isolates, severely limits treatment options. This review provides an overview on the key molecular mechanisms of UPEC antibiotic resistance, such as enzymatic inactivation, target-site mutations, efflux pump activity, and biofilm formation. Beyond conventional antibiotics, special emphasis is placed on phytochemical strategies as promising alternatives. Flavonoids, alkaloids, terpenoids, and essential oils exhibit antibacterial, anti-adhesive, and antibiofilm properties. These natural bioactive compounds modulate motility, suppress fimbrial expression, inhibit quorum sensing, and enhance antibiotic efficacy, acting both as standalone agents and as adjuvants. [...] | ca |
| dc.format.extent | 25 p. | ca |
| dc.language.iso | eng | ca |
| dc.publisher | MDPI | ca |
| dc.relation.ispartof | Antibiotics. 2025 Dec;14(12):1242 | ca |
| dc.rights | Attribution 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject.other | Uropathogenic Escherichia coli | ca |
| dc.subject.other | Urinary tract infections | ca |
| dc.subject.other | Antibiotic resistance | ca |
| dc.subject.other | Phytochemicals | ca |
| dc.subject.other | Complementary therapies | ca |
| dc.subject.other | Efflux pump | ca |
| dc.subject.other | Biofilm | ca |
| dc.title | Current insights into antibiotic resistance in uropathogenic Escherichia coli and interventions using selected bioactive phytochemicals | ca |
| dc.type | info:eu-repo/semantics/article | ca |
| dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
| dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
| dc.embargo.terms | cap | ca |
| dc.identifier.doi | 10.3390/antibiotics14121242 | ca |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Articles [2]


